133 related articles for article (PubMed ID: 30189384)
21. Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
Radujkovic A; Guglielmi C; Bergantini S; Iacobelli S; van Biezen A; Milojkovic D; Gratwohl A; Schattenberg AV; Verdonck LF; Niederwieser DW; de Witte T; Kröger N; Olavarria E;
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1230-6. PubMed ID: 25797175
[TBL] [Abstract][Full Text] [Related]
22. Alloimmune Myositis as Paraneoplastic Complication of an Oral Squamous Cell Carcinoma After Severe Chronic Graft vs Host Disease or a Manifestation of Chronic Graft vs Host Disease? A Case Report and Literature Discussion.
Woelfinger P; Hauptrock B; Kriege O; Wagner W; Heider J; Schwarting A; Birklein F; Theobald M; Wagner-Drouet EM
Transplant Proc; 2021 May; 53(4):1365-1368. PubMed ID: 33478746
[TBL] [Abstract][Full Text] [Related]
23. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
Liao YP; Jiang JL; Zou WY; Xu DR; Li J
World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
[TBL] [Abstract][Full Text] [Related]
24. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome.
Skert C; Patriarca F; Sperotto A; Cerno M; Filì C; Zaja F; Stocchi R; Geromin A; Damiani D; Fanin R
Haematologica; 2006 Feb; 91(2):258-61. PubMed ID: 16461315
[TBL] [Abstract][Full Text] [Related]
25. Central nervous system graft-versus-host disease post allogeneic stem cell transplant.
Shortt J; Hutton E; Faragher M; Spencer A
Br J Haematol; 2006 Jan; 132(2):245-7. PubMed ID: 16398660
[No Abstract] [Full Text] [Related]
26. Graft-Versus-Host Disease Presenting as a Myositis and Myonecrosis.
Patel DM; Newallo DS; Barron B
Clin Nucl Med; 2020 Nov; 45(11):e495-e497. PubMed ID: 32701802
[TBL] [Abstract][Full Text] [Related]
27. Low-dose alemtuzumab vs. standard policy for prevention of graft-versus-host disease in unrelated and related allogeneic stem cell transplantation-a matched pair analysis.
Busemann C; Neumann T; Schulze M; Klenner A; Thiele T; Greinacher A; Dölken G; Krüger WH
Ann Hematol; 2013 Jul; 92(7):945-52. PubMed ID: 23463451
[TBL] [Abstract][Full Text] [Related]
28. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
29. Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients.
Fujimaki K; Mori T; Kida A; Tanaka M; Kawai N; Matsushima T; Kishi K; Fujisawa S; Sakura T; Yokota A; Kanda Y; Taguchi J; Akiyama H; Kanamori H; Maruta A; Okamoto S; Sakamaki H
Int J Hematol; 2006 Dec; 84(5):432-7. PubMed ID: 17189225
[TBL] [Abstract][Full Text] [Related]
30. Ocular graft-versus-host disease: a review.
Shikari H; Antin JH; Dana R
Surv Ophthalmol; 2013; 58(3):233-51. PubMed ID: 23541042
[TBL] [Abstract][Full Text] [Related]
31. Dermoscopic Follow-Up of the Skin towards Acute Graft-versus-Host-Disease in Patients after Allogeneic Hematopoietic Stem Cell Transplantation.
Kaminska-Winciorek G; Czerw T; Kruzel T; Giebel S
Biomed Res Int; 2016; 2016():4535717. PubMed ID: 27446950
[TBL] [Abstract][Full Text] [Related]
32. Concurrent Hepatic Tuberculosis and Hepatic Graft-versus-host Disease in an Allogeneic Hematopoietic Stem Cell Transplant Recipient: A Case Report.
Zhao Z; Leow WQ
Transplant Proc; 2017 Sep; 49(7):1659-1662. PubMed ID: 28774674
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to 70 kD and 90 kD heat shock proteins are associated with graft-versus-host disease in peripheral blood stem cell transplant recipients.
Goral J; Shenoy S; Mohanakumar T; Clancy J
Clin Exp Immunol; 2002 Mar; 127(3):553-9. PubMed ID: 11966775
[TBL] [Abstract][Full Text] [Related]
34. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
[TBL] [Abstract][Full Text] [Related]
35. Recipient interferon-gamma 3/3 genotype contributes to the development of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Bogunia-Kubik K; Mlynarczewska A; Wysoczanska B; Lange A
Haematologica; 2005 Mar; 90(3):425-6. PubMed ID: 15749687
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
37. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
[TBL] [Abstract][Full Text] [Related]
38. Graft versus self (GvS) against T-cell autoantigens is a mechanism of graft-host interaction.
Mirza N; Zierhut M; Korn A; Bornemann A; Vogel W; Schmid-Horch B; Bethge WA; Stevanović S; Salih HR; Kanz L; Rammensee HG; Haen SP
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13827-13832. PubMed ID: 27834728
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
40. Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease.
Sugio T; Kato K; Aoki T; Ohta T; Saito N; Yoshida S; Kawano I; Henzan H; Kadowaki M; Takase K; Muta T; Miyawaki K; Yamauchi T; Shima T; Takashima S; Mori Y; Yoshimoto G; Kamezaki K; Takenaka K; Iwasaki H; Ogawa R; Ohno Y; Eto T; Kamimura T; Miyamoto T; Akashi K
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1608-1614. PubMed ID: 27220263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
